Federally, health insurers cannot use this data under GINA[0] and SB41[1] in California requires explicit permission be granted by the customer in order for the data to be shared with 3rd parties. In general, however, insurance companies are going to be reluctant to trust this information as it’s not established that it has real medical value outside the handful of markers we’ve clearly identified.

[0]: https://medlineplus.gov/genetics/understanding/dtcgenetictes...

[1]: https://leginfo.legislature.ca.gov/faces/billTextClient.xhtm...